Drug Shortage Report for OMNIPAQUE 300
| Report ID | 160389 |
| Drug Identification Number | 02172747 |
| Brand name | OMNIPAQUE 300 |
| Common or Proper name | iohexol injection USP |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOHEXOL |
| Strength(s) | 647MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVASCULAR SUBARACHNOIDAL |
| Packaging size | 200 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-05-12 |
| Estimated end date | 2023-03-31 |
| Actual end date | 2023-02-28 |
| Shortage status | Resolved |
| Updated date | 2023-03-01 |
| Company comments | Covid Related Shutdown in China. This is a fluid situation that we are working through daily. We will keep all customers informed on what orders to expect during this period so they can plan accordingly. |
| Health Canada comments | Canadian Association of Radiologists: Statement on Iodinated Contrast Media Shortage - https://car.ca/news/statement-on-iodinated-contrast-media-shortage/ |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2023-03-01 | English | Compare |
| v11 | 2023-02-28 | French | Compare |
| v10 | 2023-02-28 | English | Compare |
| v9 | 2022-09-20 | French | Compare |
| v8 | 2022-09-20 | English | Compare |
| v7 | 2022-07-05 | French | Compare |
| v6 | 2022-07-05 | English | Compare |
| v5 | 2022-05-27 | French | Compare |
| v4 | 2022-05-27 | English | Compare |
| v3 | 2022-05-13 | English | Compare |
| v2 | 2022-05-12 | French | Compare |
| v1 | 2022-05-12 | English | Compare |
Showing 1 to 12 of 12